Cheng, Z., Wang, S., Li, F., Jin, C., Mo, C., Zheng, J., . . . Gu, D. The potential adverse effects of hypodermic glucagon‐like peptide ‐1 receptor agonist on patients with type 2 diabetes: A population‐based study. Wiley.
Chicago Style (17th ed.) CitationCheng, Zhiyuan, et al. The Potential Adverse Effects of Hypodermic Glucagon‐like Peptide ‐1 Receptor Agonist on Patients with Type 2 Diabetes: A Population‐based Study. Wiley.
MLA (9th ed.) CitationCheng, Zhiyuan, et al. The Potential Adverse Effects of Hypodermic Glucagon‐like Peptide ‐1 Receptor Agonist on Patients with Type 2 Diabetes: A Population‐based Study. Wiley.
Warning: These citations may not always be 100% accurate.